Nat Calloway's Insider Trades & SAST Disclosures
Nat Calloway's most recent trade in Lifecore Biomedical Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on July 8, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nat Calloway.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Nathaniel Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 30,000 | 58,069 (0%) | 0% | - | Common Stock | |
| Anebulo Pharmaceuticals Inc | Nathaniel Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 41,667 | 41,667 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Nathaniel Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 1,655 | 1,655 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Nat Calloway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,981 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nat Calloway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,981 | 28,069 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Calloway Nat | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 5,906 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Calloway Nat | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 5,906 | 24,088 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nat Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 18,182 | 18,182 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nat Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 3,981 | 3,981 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nat Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 5,906 | 5,906 | - | - | Restricted Stock Unit | |
| Anebulo Pharmaceuticals Inc | Nat Calloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 59,149 | 59,149 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges